RI
RTW Investments Portfolio holdings
AUM
$9.98B
1-Year Est. Return
115.73%
This Fund
S&P 500
1 Year Est. Return
+115.73%
AUM
$9.98B
AUM Growth
+$1.87B
(+23%)
Holding
103
Top Buys
| 1 | +$321M | |
| 2 | +$209M | |
| 3 | +$180M | |
| 4 |
Repligen
RGEN
|
+$167M |
| 5 |
Cogent Biosciences
COGT
|
+$116M |
Top Sells
| 1 | +$496M | |
| 2 | +$260M | |
| 3 | +$191M | |
| 4 |
Natera
NTRA
|
+$104M |
| 5 |
Stryker
SYK
|
+$89.3M |
Sector Composition
| 1 | Healthcare | 99.9% |
| 2 | Financials | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLTE
26
Belite Bio
BLTE
$7.14B
| $114M | 1.15% |
715,332
+402,832
|
|
||
27
UroGen Pharma
URGN
$1.02B
| $106M | 1.07% |
4,543,895
|
|
||
28
Xencor
XNCR
$912M
| $104M | 1.04% |
6,777,461
+556,407
|
|
||
29
Insulet
PODD
$17.4B
| $92.3M | 0.92% |
+324,600
|
|
||
30
Taysha Gene Therapies
TSHA
$1.24B
| $90.2M | 0.9% |
16,398,297
-7,955,994
|
|
||
31
Masimo
MASI
$9.42B
| $88.9M | 0.89% |
683,294
|
|
||
32
uniQure
QURE
$974M
| $88.8M | 0.89% |
3,711,462
-713,506
|
|
||
|
33
Stryker
SYK
$148B
| $86.1M | 0.86% |
245,000
-245,000
|
|
||
34
CG Oncology
CGON
$4.86B
| $83.5M | 0.84% |
2,012,127
+310,911
|
|
||
35
Castle Biosciences
CSTL
$863M
| $82.3M | 0.82% |
+2,115,237
|
|
||
36
Immunovant
IMVT
$5.64B
| $80.8M | 0.81% |
+3,177,850
|
|
||
|
BBNX
37
Beta Bionics
BBNX
$561M
| $76.2M | 0.76% |
2,500,000
-799,191
|
|
||
38
GH Research
GHRS
$921M
| $75.4M | 0.75% |
5,933,815
+364,251
|
|
||
39
Replimune Group
REPL
$632M
| $69.4M | 0.7% |
7,140,352
+744,620
|
|
||
40
Ultragenyx Pharmaceutical
RARE
$2.26B
| $69M | 0.69% |
3,000,139
-258,127
|
|
||
41
Crinetics Pharmaceuticals
CRNX
$4.21B
| $62.9M | 0.63% |
1,351,326
+478,939
|
|
||
|
ORKA
42
Oruka Therapeutics
ORKA
$1.67B
| $62.4M | 0.62% |
2,058,148
+112,499
|
|
||
43
Rocket Pharmaceuticals
RCKT
$542M
| $62.1M | 0.62% |
17,687,772
|
|
||
|
CMPS
44
Compass Pathways
CMPS
$783M
| $60.4M | 0.61% |
8,757,390
+50,000
|
|
||
45
Intuitive Surgical
ISRG
$179B
| $57.3M | 0.57% |
101,228
-101,228
|
|
||
46
RAPT Therapeutics
RAPT
$1.68B
| $55.5M | 0.56% |
1,637,165
+166,666
|
|
||
47
Celcuity
CELC
$5.17B
| $54.9M | 0.55% |
+550,160
|
|
||
48
Verastem
VSTM
$431M
| $50.8M | 0.51% |
6,576,306
+1,150,000
|
|
||
49
Alkermes
ALKS
$4.97B
| $46.8M | 0.47% |
1,672,356
|
|
||
|
CNTA
50
Centessa Pharmaceuticals
CNTA
$3.97B
| $44.8M | 0.45% |
1,790,837
-500,910
|
|